U
Umed
A technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries
About Umed
uMed is a healthcare technology company that accelerates medical research by building consented patient cohorts and generating real-time clinical data insights. The company serves life science companies, healthcare professionals, and patients. Operating in the medical research and healthcare sectors, uMed's business model focuses on creating unique, exclusive data that meets specific research requirements. This data is generated by integrating clinical outcomes from deeply characterized patient cohorts. uMed makes money by providing these valuable data insights and research capabilities to its clients. The company also empowers patients to participate in relevant medical research opportunities from the comfort of their homes, while healthcare professionals benefit from automated processes that reduce their workload and enable participation in more studies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Employees
- 93
- Open positions
- None listed
- Dealroom signal
- 84.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Core AI, Tech for Hospitals and Clinics, Tech for Medical Professionals, Physician Support Tools, Health Office Tools, AI Drug Discovery, Techbio
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2023 | $13M | $52M | Playfair Capital · 11.2 Capital · AlbionVC · Delin Ventures | ↗ |
| SEED✓Equity / VC | Dec 2020 | $4.9M | $20M | 11.2 Capital · Delin Ventures · Playfair Capital · AlbionVC | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Umed is 9.1K monthly website visits, up 1795.8% over the last three months. Umed's team grew 47.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Playfair Capital
11.2 Capital
Delin Ventures
AlbionVC
Other known investors1 additional known investor
Chris Smith
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Umed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Umed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.